Article Information
History
- October 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Summer Internship Program in Oncology Disease Area, Novartis Institutes of Biomedical Research, Cambridge MA, USA
- 2Oncology Disease Area, Novartis Institutes of Biomedical Research, Cambridge MA, USA
- 3Oncology Disease Area, Novartis Institutes of Biomedical Research, Basel, Switzerland
- ↵*To whom correspondence should be addressed. Contact:
Joel P. Wagner, Email: joel.wagner{at}novartis.com, Noemi Di Nanni: Email: noemi.di_nanni{at}novartis.com
Competing Interests Statement: JPW is a shareholder of Novartis Pharmaceuticals.
Posted October 19, 2021.
Inferring copy number variation from gene expression data: methods, comparisons, and applications to oncology
